|
Jul 30
|
OTCQB Venture Virtual Investor Conference Agenda Announced for August 1st
|
|
May 15
|
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
|
|
May 7
|
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
|